Skip to content
Helix logo — Helix is the leading population genomics and precision healt...

Helix

Helix is the leading population genomics and precision health organization.

Founded 2015 United States San Mateo, United States 622 employees Series C Total: $411.00M Big Data, Biotechnology +6

General Information

Company Name Helix
Founded Year 2015
Location United States San Mateo, United States
Employees 622
Industries Big Data, Biotechnology, Blockchain +5
Funding Stage Series C
Business Model B2B, B2B2C, Platform
Revenue Model Service Fee, Data Monetization, Subscription
Hiring 11 roles posted in the month to 8 Nov 2026
Social

BounceWatch is an independent company data service, not affiliated with Helix. To contact Helix, visit helix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Helix compare?

A PDF of Helix and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Helix soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Actively Hiring Nov 06, 2026

Hiring for 11 positions in the last 30 days.

Award Received Nov 05, 2026

Helix was named Overall Genomics Company of the Year in the 2026 BioTech Breakthrough Awards.

New Partnership Nov 03, 2026

Helix partnered with Precure, LLC to generate clinical whole-genome sequencing and multi-omics data for ~1M biospecimens.

Event Participation Nov 02, 2026

Helix is attending the Becker's Healthcare CEO + CFO Roundtable in Chicago, exhibiting at Booth 309.

Growth Metrics Oct 29, 2026

Helix shared outcomes from a three-year outcomes study across 527,000 participants via the Helix Research Network.

AI Insight

Bounce Watch AI
1 week ago

Helix is demonstrating robust strategic momentum, evidenced by a major partnership to generate 1 million biospecimens' worth of genomic data and the successful completion of a three-year outcomes study involving over 500,000 participants. This significant expansion in data generation and proven research impact, coupled with recent industry recognition as "Overall Genomics Company of the Year," underscores their leadership and scaling capabilities in population genomics. The active hiring and participation in key industry events further signal aggressive market penetration and operational growth.

Signal Types
Traction Partnership Recognition Hiring Market Presence
Strategic Labels
Data Expansion Market Leadership Operational Growth
Next Move: Expansion
·
Impact: 9/10
·
Ideal For: Growth Equity Investors — Precision Health, Life Sciences VCs

About Helix

Helix, founded in 2015, is a pioneer in the integration of genomic data within the healthcare sector, positioning itself as a leader in population genomics and precision health. The company collaborates with health systems, life sciences companies, and payers to foster the adoption of genomic data in patient care and therapeutic development.

Based in the United States, Helix operates at the intersection of several cutting-edge industries, including Big Data, Biotechnology, and Health Care. This positions the company to capitalize on the increasing demand for advanced health solutions and data integration capabilities across numerous market segments.

In June 2021, Helix secured a $50.00M investment in its Series C funding round, with participation from prominent investors such as Kleiner Perkins, DFJ Growth, Warburg Pincus, Mayo Clinic, and Temasek. This substantial backing underscores investor confidence in Helix's growth potential and its innovative approach to genomics integration in healthcare.

Business keywords: Population Genomics, Precision Health, Precision Medicine, Next Generation Sequencing, Exome Sequencing, Bioinformatics, Genomic Data Integration, Clinical Care, Therapeutic Development, Translational Research, Health System Strategy, CLIA/CAP Certified Lab, Exome+ Assay, Disease Screening, Genomic Research

Services & Products

Seamless Genetic Testing
Population Genomics Solutions
Genomic Data Integration
Precision Health Network
Comprehensive Genomic Insights

Target Customers

Healthcare Providers Health Systems Life Sciences Organizations Patients Research Participants

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $50.00M 5
Kleiner Perkins, DFJ Growth +3
01 Jun 2021
Grant $33.00M 1
National Institute of Health
01 Jul 2020
Series B $200.00M 7
Kleiner Perkins, DFJ Growth +5
01 Mar 2018
Early VC $20.00M 2
Kleiner Perkins, Casdin Capital
01 Oct 2017
Series A $100.00M 5
LaunchCapital, Warburg Pincus +3
01 Aug 2015
Series A $8.00M 4
Obvious Ventures, Andreessen Horowitz/ a16z +2
01 May 2014
Seed Undisclosed -
01 Feb 2009

Helix Alternatives & Competitors

View All Alternatives
Helix vs
Congenica
Congenica United Kingdom

Driving Precision Medicine

Acquired
23 employees
Biotechnology, Health Care
Helix vs

Personalized Genomics For A Healthier Future

Acquired
643 employees
Biotechnology, Health Care
Helix vs
Artisan Biomed
Artisan Biomed South Africa

Unraveling the African Genome to transform health care

1 employees
Biotechnology, Health and Wellness

FAQ About Helix

Helix is the leading population genomics and precision health organization.
Helix was founded in 2015.
Helix is headquartered in San Mateo, United States.
Helix operates in Big Data, Biotechnology, Blockchain, Crypto, Fintech, Health Care, Health and Wellness and Clean Energy. Its work centres on Population Genomics, Precision Health, Precision Medicine and Next Generation Sequencing. Its customers include Healthcare Providers, Health Systems and Life Sciences Organizations.
Helix has a B2B, B2B2C and Platform business model. Its revenue comes from Service Fee, Data Monetization and Subscription.
Helix has approximately 622 employees.
Helix has completed 7 funding rounds, raising a total of $411.00M. The latest funding stage is Series C.
Helix offers: Seamless Genetic Testing, Population Genomics Solutions, Genomic Data Integration, Precision Health Network, Comprehensive Genomic Insights.
Top alternatives and competitors to Helix include Congenica, Strand Life Sciences, Artisan Biomed, Genomics, Lifebit. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Helix and Congenica are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Helix, https://bouncewatch.com/company/helix-1, updated 8 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout